The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
- 5 May 2011
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 118 (9), 1819-1826
- https://doi.org/10.1016/j.ophtha.2011.02.018
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyOphthalmology, 2009
- An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaBritish Journal of Ophthalmology, 2009
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- Glial Cell–Derived Cytokines Attenuate the Breakdown of Vascular Integrity in Diabetic RetinopathyDiabetes, 2007
- Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2007
- Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal AdministrationPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2005
- Breakdown of the Inner and Outer Blood Retinal Barrier in Streptozotocin-Induced DiabetesExperimental Eye Research, 1998
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988